Verus Pharmaceuticals Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 10
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $310M
Latest Deal Amount

Verus Pharmaceuticals General Information

Description

Provider of solutions for the treatment of asthma, allergies, and related diseases and conditions. The company also offers Twinject, an epinephrine auto-injector for anaphylaxis. It is differentiated by its pediatric orientation and its strong financial position and experienced management team, which allows the company to capitalize on an extensive network to build its product portfolio and pursue complementary transactions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Acquirer
Primary Office
  • 12671 High Bluff Drive
  • Suite 200
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Verus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 24-Sep-2007 $310M 0000 00000 Completed Product Development
1. Early Stage VC (Series A) 10-Jun-2005 0000 0000 00000 Completed Product Development
To view Verus Pharmaceuticals’s complete valuation and funding history, request access »

Verus Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.0 00.0 00.0 00.000
To view Verus Pharmaceuticals’s complete cap table history, request access »

Verus Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Robert Keith President & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Verus Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Verus Pharmaceuticals Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Athenian Venture Partners Venture Capital Minority 000 0000 000000 0
CDIB BioScience Venture Management Venture Capital Minority 000 0000 000000 0
Domain Associates Venture Capital Minority 000 0000 000000 0
Greenspring Associates Venture Capital Minority 000 0000 000000 0
MPM Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Verus Pharmaceuticals Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000-00000 00 06-Jul-2005 000000000 00000 00 Buildings and Property 000000 00000
To view Verus Pharmaceuticals’s complete investments history, request access »

Verus Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000-00000 00 06-Jul-2005 000000000 00000 00 Completed
  • 00000 000000000000
To view Verus Pharmaceuticals’s complete exits history, request access »